BioRestorative Therapies Inc. Common Stock (NV) (BRTX)
BRTX trades on Nasdaq in Health Care, Managed Health Care. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.59
-9.14% on the day
Market cap
$2.2M
Nano cap
Revenue · 2025
$360K
-10.3% on 2024
Net income · 2025
-$14.2M
-3959.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BRTX on Nasdaq |
| Sector | Health Care |
| Industry | Managed Health Care |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001505497 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $360K |
| Net income | -$14.2M |
| Operating income | -$15.6M |
| Net margin | -3959.4% |
| Operating margin | -4350.1% |
| Revenue growth | -10.3% |
| Cash | $1.5M |
| Total assets | $4.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 6.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-04-30 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-05-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-09 |
| Latest proxy | DEF 14A | 2026-04-13 |
Source: SEC EDGAR submissions feed, 754 recent filings. All filings on EDGAR.
Peers in Managed Health Care
No other listed companies with a market cap share this industry.
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier